Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (27)

2024

  1. An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial)

    International Journal of Gynecological Cancer, Vol. 34, Núm. 6, pp. 942-945

  2. Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line

    Clinical and Translational Oncology

2023

  1. A pharmacometrics model to define docetaxel target in early breast cancer

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 2, pp. 727-736

2021

  1. Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis

    Clinical and Translational Oncology, Vol. 23, Núm. 9, pp. 1934-1941

2019

  1. Dietary inflammatory index and incidence of breast cancer in the SUN project

    Clinical Nutrition, Vol. 38, Núm. 5, pp. 2259-2268

2018

  1. Erratum: Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial (Brachytherapy (2018) 17(5) (734–741), (S1538472118300898) (10.1016/j.brachy.2018.04.007))

    Brachytherapy

  2. Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial

    Brachytherapy, Vol. 17, Núm. 5, pp. 734-741

2016

  1. Long-Term Results of a Phase II Trial of Concomitant Cisplatin-Paclitaxel Chemoradiation in Locally Advanced Cervical Cancer

    International Journal of Gynecological Cancer, Vol. 26, Núm. 6, pp. 1162-1168

2011

  1. A novel mutation in BRCA1 linked to breast and ovarian cancer and a genotype-phenotype correlation

    Oncology Letters, Vol. 2, Núm. 5, pp. 807-809

2010

  1. A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family

    Breast Cancer Research and Treatment, Vol. 121, Núm. 1, pp. 219-220

  2. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer

    International Journal of Gynecological Cancer, Vol. 20, Núm. 1, pp. 133-140

  3. Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer

    Cancer Chemotherapy and Pharmacology, Vol. 65, Núm. 3, pp. 457-465

2007

  1. Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Núm. 9, pp. 1396-1405

  2. Phase I and Pharmacokinetic Study of Gemcitabine Administered at Fixed-Dose Rate, Combined with Docetaxel/Melphalan/Carboplatin, with Autologous Hematopoietic Progenitor-Cell Support, in Patients with Advanced Refractory Tumors

    Biology of Blood and Marrow Transplantation, Vol. 13, Núm. 11, pp. 1324-1337

2006

  1. Determination of docetaxel and paclitaxel in human plasma by high-performance liquid chromatography: Validation and application to clinical pharmacokinetic studies

    Therapeutic Drug Monitoring, Vol. 28, Núm. 2, pp. 199-205

2004

  1. A single prior course of BCNU-cisplatin chemotherapy has a significant deleterious effect on mobilization kinetics of otherwise untreated patients

    Bone Marrow Transplantation, Vol. 33, Núm. 5, pp. 499-502

  2. Paclitaxel, cisplatin, and vinorelbine combination chemotherapy in metastatic non-small-cell lung cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 27, Núm. 3, pp. 299-303

2003

  1. F-18-FDG positron emission tomography in the diagnosis of ovarian recurrence. Comparison with CT scan and CA 125

    Revista Espanola de Medicina Nuclear, Vol. 22, Núm. 4, pp. 217-223

  2. Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer

    Oncology, Vol. 64, Núm. 1, pp. 28-35

2002

  1. Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer: A feasibility pilot study

    Oncology, Vol. 63, Núm. 3, pp. 254-265